Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

1.

Production of Cyr61 protein is modulated by extracellular acidification and PI3K/Akt signaling in prostate carcinoma PC-3 cells.

Lee YJ, Lee DM, Lee SH.

Food Chem Toxicol. 2013 Aug;58:169-76. doi: 10.1016/j.fct.2013.04.035. Epub 2013 Apr 24.

PMID:
23623839
[PubMed - indexed for MEDLINE]
2.

Suppression of human prostate cancer PC-3 cell growth by N-acetylcysteine involves over-expression of Cyr61.

Lee YJ, Lee DM, Lee CH, Heo SH, Won SY, Im JH, Cho MK, Nam HS, Lee SH.

Toxicol In Vitro. 2011 Feb;25(1):199-205. doi: 10.1016/j.tiv.2010.10.020. Epub 2010 Nov 3.

PMID:
21055460
[PubMed - indexed for MEDLINE]
3.

Brassinin induces apoptosis in PC-3 human prostate cancer cells through the suppression of PI3K/Akt/mTOR/S6K1 signaling cascades.

Kim SM, Park JH, Kim KD, Nam D, Shim BS, Kim SH, Ahn KS, Choi SH, Ahn KS.

Phytother Res. 2014 Mar;28(3):423-31. doi: 10.1002/ptr.5010. Epub 2013 May 20.

PMID:
23686889
[PubMed - indexed for MEDLINE]
4.

[Cyr61 expression influences cancer cell proliferation and apoptosis via PI3K pathway in human ovarian carcinoma cells].

Xiao L, He C, Li X, Chen Y, Zhou JD.

Zhonghua Fu Chan Ke Za Zhi. 2012 Aug;47(8):616-20. Chinese.

PMID:
23141184
[PubMed - indexed for MEDLINE]
5.

Bcl-xL mediates a survival mechanism independent of the phosphoinositide 3-kinase/Akt pathway in prostate cancer cells.

Yang CC, Lin HP, Chen CS, Yang YT, Tseng PH, Rangnekar VM, Chen CS.

J Biol Chem. 2003 Jul 11;278(28):25872-8. Epub 2003 May 8.

PMID:
12738789
[PubMed - indexed for MEDLINE]
Free Article
6.

CYR61 controls p53 and NF-κB expression through PI3K/Akt/mTOR pathways in carboplatin-induced ovarian cancer cells.

Lee KB, Byun HJ, Park SH, Park CY, Lee SH, Rho SB.

Cancer Lett. 2012 Feb 1;315(1):86-95. doi: 10.1016/j.canlet.2011.10.016. Epub 2011 Oct 21.

PMID:
22078465
[PubMed - indexed for MEDLINE]
7.

Activation and cross-talk between Akt, NF-kappaB, and unfolded protein response signaling in 1-LN prostate cancer cells consequent to ligation of cell surface-associated GRP78.

Misra UK, Deedwania R, Pizzo SV.

J Biol Chem. 2006 May 12;281(19):13694-707. Epub 2006 Mar 16.

PMID:
16543232
[PubMed - indexed for MEDLINE]
Free Article
8.

Parathyroid hormone-related protein regulates cell survival pathways via integrin alpha6beta4-mediated activation of phosphatidylinositol 3-kinase/Akt signaling.

Bhatia V, Mula RV, Weigel NL, Falzon M.

Mol Cancer Res. 2009 Jul;7(7):1119-31. doi: 10.1158/1541-7786.MCR-08-0568. Epub 2009 Jul 7.

PMID:
19584267
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Targeting the Vav3 oncogene enhances docetaxel-induced apoptosis through the inhibition of androgen receptor phosphorylation in LNCaP prostate cancer cells under chronic hypoxia.

Nomura T, Yamasaki M, Hirai K, Inoue T, Sato R, Matsuura K, Moriyama M, Sato F, Mimata H.

Mol Cancer. 2013 Apr 8;12:27. doi: 10.1186/1476-4598-12-27.

PMID:
23566222
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Ran is a potential therapeutic target for cancer cells with molecular changes associated with activation of the PI3K/Akt/mTORC1 and Ras/MEK/ERK pathways.

Yuen HF, Chan KK, Grills C, Murray JT, Platt-Higgins A, Eldin OS, O'Byrne K, Janne P, Fennell DA, Johnston PG, Rudland PS, El-Tanani M.

Clin Cancer Res. 2012 Jan 15;18(2):380-91. doi: 10.1158/1078-0432.CCR-11-2035. Epub 2011 Nov 16.

PMID:
22090358
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Cyr61 is overexpressed in gliomas and involved in integrin-linked kinase-mediated Akt and beta-catenin-TCF/Lef signaling pathways.

Xie D, Yin D, Tong X, O'Kelly J, Mori A, Miller C, Black K, Gui D, Said JW, Koeffler HP.

Cancer Res. 2004 Mar 15;64(6):1987-96.

PMID:
15026334
[PubMed - indexed for MEDLINE]
Free Article
12.

Long-term androgen-ablation causes increased resistance to PI3K/Akt pathway inhibition in prostate cancer cells.

Pfeil K, Eder IE, Putz T, Ramoner R, Culig Z, Ueberall F, Bartsch G, Klocker H.

Prostate. 2004 Feb 15;58(3):259-68.

PMID:
14743465
[PubMed - indexed for MEDLINE]
13.

The phosphotidyl inositol 3-kinase/Akt signal pathway is involved in interleukin-6-mediated Mcl-1 upregulation and anti-apoptosis activity in basal cell carcinoma cells.

Jee SH, Chiu HC, Tsai TF, Tsai WL, Liao YH, Chu CY, Kuo ML.

J Invest Dermatol. 2002 Nov;119(5):1121-7.

PMID:
12445202
[PubMed - indexed for MEDLINE]
Free Article
14.

Serum bioactive lysophospholipids prevent TRAIL-induced apoptosis via PI3K/Akt-dependent cFLIP expression and Bad phosphorylation.

Kang YC, Kim KM, Lee KS, Namkoong S, Lee SJ, Han JA, Jeoung D, Ha KS, Kwon YG, Kim YM.

Cell Death Differ. 2004 Dec;11(12):1287-98.

PMID:
15297884
[PubMed - indexed for MEDLINE]
Free Article
15.

Mesothelin confers pancreatic cancer cell resistance to TNF-α-induced apoptosis through Akt/PI3K/NF-κB activation and IL-6/Mcl-1 overexpression.

Bharadwaj U, Marin-Muller C, Li M, Chen C, Yao Q.

Mol Cancer. 2011 Aug 31;10:106. doi: 10.1186/1476-4598-10-106.

PMID:
21880146
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Dual inhibition of Bcl-2 and Bcl-xL strikingly enhances PI3K inhibition-induced apoptosis in human myeloid leukemia cells through a GSK3- and Bim-dependent mechanism.

Rahmani M, Aust MM, Attkisson E, Williams DC Jr, Ferreira-Gonzalez A, Grant S.

Cancer Res. 2013 Feb 15;73(4):1340-51. doi: 10.1158/0008-5472.CAN-12-1365. Epub 2012 Dec 12.

PMID:
23243017
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Saposin C promotes survival and prevents apoptosis via PI3K/Akt-dependent pathway in prostate cancer cells.

Lee TJ, Sartor O, Luftig RB, Koochekpour S.

Mol Cancer. 2004 Nov 17;3:31.

PMID:
15548330
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Tanshinone IIA induces mitochondria dependent apoptosis in prostate cancer cells in association with an inhibition of phosphoinositide 3-kinase/AKT pathway.

Won SH, Lee HJ, Jeong SJ, Lee HJ, Lee EO, Jung DB, Shin JM, Kwon TR, Yun SM, Lee MH, Choi SH, Lü J, Kim SH.

Biol Pharm Bull. 2010;33(11):1828-34.

PMID:
21048307
[PubMed - indexed for MEDLINE]
Free Article
19.

Cysteine-rich 61 (CCN1) enhances chemotactic migration, transendothelial cell migration, and intravasation by concomitantly up-regulating chemokine receptor 1 and 2.

Lin BR, Chang CC, Chen LR, Wu MH, Wang MY, Kuo IH, Chu CY, Chang KJ, Lee PH, Chen WJ, Kuo ML, Lin MT.

Mol Cancer Res. 2007 Nov;5(11):1111-23.

PMID:
18025257
[PubMed - indexed for MEDLINE]
Free Article
20.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk